Mirae Asset Global ETFs Holdings
ZVRA icon

Mirae Asset Global ETFs Holdings’s Zevra Therapeutics ZVRA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$243K Buy
26,093
+235
+0.9% +$2.12K ﹤0.01% 2249
2025
Q4 		$232K Buy
25,858
+962
+4% +$9.1K ﹤0.01% 2280
2025
Q3 		$237K Sell
24,896
-5,364
-18% -$53.8K ﹤0.01% 2241
2025
Q2 		$267K Sell
30,260
-1,501
-5% -$12.2K ﹤0.01% 2133
2025
Q1 		$238K Buy
31,761
+1,812
+6% +$14.4K ﹤0.01% 2238
2024
Q4 		$250K Buy
29,949
+6,877
+30% +$58.7K ﹤0.01% 2267
2024
Q3 		$160K Buy
23,072
+5,175
+29% +$35.1K ﹤0.01% 2480
2024
Q2 		$87.7K Buy
+17,897
New +$84.8K ﹤0.01% 2617

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ZVRA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Zevra Therapeutics (ZVRA) stake by 0.91% in Q1 2026, buying an estimated $2.12K and bringing the position to 26,093 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

Mirae Asset Global ETFs Holdings first reported a position in ZVRA in Q2 2024 and has held it in 8 quarters since. The position peaked at $267K in Q2 2025. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 26,093 shares of Zevra Therapeutics worth $243K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 235 Zevra Therapeutics shares in Q1 2026, an estimated $2.12K.
  • Zevra Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2249 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Zevra Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Zevra Therapeutics position peaked at $267K in Q2 2025.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.